Genoscience Pharma History
Genoscience Pharma was founded by Philippe Halfon, a renowned expert in the field of infectious diseases. Genoscience Pharma was initially dedicated to the development of antiviral compounds against Hepatitis C virus. Several protease inhibitors were developed, leading to the discovery of a new chemical entity family inhibiting autophagy, and efficient against Hepatitis C virus. Because of encouraging results of its autophagy inhibitors drug candidates in cancer stem cell lines, Genoscience Pharma has reoriented its focus on oncology, where medical needs are still unmet.